Ratings by IFS Securities (David Bouchey)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/8/2019 | Rexahn Pharmaceuticals, Inc. | REXN | Downgrade | Market Perform (Strong Buy) |
4.93 (1.81) |
-63.29% | Details | |
| 6/19/2019 | Rockwell Medical Technologies | RMTI | Downgrade | Outperform (Strong Buy) |
3.03 (0.87) |
-71.29% | Details | |
| 3/18/2019 | Rockwell Medical Technologies | RMTI | Upgrade | Strong Buy (Outperform) |
5.21 (3.03) |
-41.84% | Details | |
| 1/7/2019 | Loxo Oncology | LOXO | Downgrade | Market Perform (Outperform) |
139.87 (234.80) |
67.87% | Details | |
| 10/19/2018 | Rockwell Medical Technologies | RMTI | Downgrade | Outperform (Strong Buy) |
4.37 (5.21) |
19.22% | Details | |
| 10/8/2018 | Loxo Oncology | LOXO | Upgrade | Outperform (Market Perform) |
159.60 (139.87) |
-12.36% | Details | |
| 10/4/2018 | Rexahn Pharmaceuticals Inc. | RNN | Upgrade | Strong Buy (Outperform) |
1.85 (5.24) |
183.24% | Details |
